TY - JOUR
T1 - Monitoring and management of fibrosing interstitial lung diseases
T2 - a narrative review for practicing clinicians
AU - Nambiar, Anoop M.
AU - Walker, Christopher M.
AU - Sparks, Jeffrey A.
N1 - Publisher Copyright:
© The Author(s), 2021.
PY - 2021
Y1 - 2021
N2 - Close monitoring of patients with fibrosing interstitial lung diseases (ILDs) is important to enable prompt identification and management of progressive disease. Monitoring should involve regular assessment of physiology (including pulmonary function tests), symptoms, and, when appropriate, high-resolution computed tomography. The management of patients with fibrosing ILDs requires a multidisciplinary approach and should be individualized based on factors such as disease severity, evidence of progression, risk factors for progression, comorbidities, and the preferences of the patient. In this narrative review, we discuss how patients with fibrosing ILDs can be effectively monitored and managed in clinical practice.
AB - Close monitoring of patients with fibrosing interstitial lung diseases (ILDs) is important to enable prompt identification and management of progressive disease. Monitoring should involve regular assessment of physiology (including pulmonary function tests), symptoms, and, when appropriate, high-resolution computed tomography. The management of patients with fibrosing ILDs requires a multidisciplinary approach and should be individualized based on factors such as disease severity, evidence of progression, risk factors for progression, comorbidities, and the preferences of the patient. In this narrative review, we discuss how patients with fibrosing ILDs can be effectively monitored and managed in clinical practice.
KW - connective tissue diseases
KW - pulmonary fibrosis
KW - pulmonary function tests
KW - treatment outcome
UR - http://www.scopus.com/inward/record.url?scp=85114381014&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85114381014&partnerID=8YFLogxK
U2 - 10.1177/17534666211039771
DO - 10.1177/17534666211039771
M3 - Review article
C2 - 34477452
AN - SCOPUS:85114381014
SN - 1753-4658
VL - 15
JO - Therapeutic Advances in Respiratory Disease
JF - Therapeutic Advances in Respiratory Disease
ER -